Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(3 sites)
China
Anyang Cancer Hospital, Anyang, Henan
The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing